Fed. Circ. Backs Acacia Unit's PTAB Loss Over Stent Patent
The Federal Circuit on Friday affirmed a Patent Trial and Appeal Board decision to invalidate the asserted claims of a stent patent exclusively licensed by a unit of patent licensing company...To view the full article, register now.
Already a subscriber? Click here to view full article